Literature DB >> 31401345

Pregnancy and multiple sclerosis: Clinical effects across the lifespan.

Ai-Lan Nguyen1, Alana Eastaugh2, Anneke van der Walt3, Vilija G Jokubaitis3.   

Abstract

Multiple sclerosis (MS) is commonly diagnosed in women of childbearing age. Having a greater understanding of the effects of pregnancy on the course of MS will lead to improved family-planning counselling for women. We found well-established evidence for a protective effect of pregnancy on relapse occurrence in historical cohorts. More recent studies suggest that the protective effect of pregnancy against relapse may be lost in those women with more active disease treated with high efficacy therapies. Furthermore, a strong body of evidence suggests that gravidity after diagnosis of MS does not lead to worse long-term outcomes. More contentious however, is whether pregnancy can delay a first episode of demyelination or a confirmed diagnosis of MS. This review provides a detailed analysis of the literature relating to the clinical effects of pregnancy on MS outcomes across a woman's reproductive lifespan. Crown
Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disability; Gravidity; Multiple sclerosis; Parity; Pregnancy; Relapse

Mesh:

Year:  2019        PMID: 31401345     DOI: 10.1016/j.autrev.2019.102360

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

1.  Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.

Authors:  Wei Zhen Yeh; Putu Ayu Widyastuti; Anneke Van der Walt; Jim Stankovich; Eva Havrdova; Dana Horakova; Karolina Vodehnalova; Serkan Ozakbas; Sara Eichau; Pierre Duquette; Tomas Kalincik; Francesco Patti; Cavit Boz; Murat Terzi; Bassem I Yamout; Jeannette Lechner-Scott; Patrizia Sola; Olga G Skibina; Michael Barnett; Marco Onofrj; Maria José Sá; Pamela Ann McCombe; Pierre Grammond; Radek Ampapa; Francois Grand'Maison; Roberto Bergamaschi; Daniele L A Spitaleri; Vincent Van Pesch; Elisabetta Cartechini; Suzanne Hodgkinson; Aysun Soysal; Albert Saiz; Melissa Gresle; Tomas Uher; Davide Maimone; Recai Turkoglu; Raymond Mm Hupperts; Maria Pia Amato; Franco Granella; Celia Oreja-Guevara; Ayse Altintas; Richard A Macdonell; Tamara Castillo-Trivino; Helmut Butzkueven; Raed Alroughani; Vilija G Jokubaitis
Journal:  Neurology       Date:  2021-04-20       Impact factor: 9.910

2.  The MSBase pregnancy, neonatal outcomes, and women's health registry.

Authors:  Vilija G Jokubaitis; Olga Skibina; Raed Alroughani; Ayse Altintas; Helmut Butzkueven; Sara Eichau; Yara Fragoso; Kerstin Hellwig; Stella E Hughes; Louise Rath; Anneke van der Walt; Orla Gray
Journal:  Ther Adv Neurol Disord       Date:  2021-04-12       Impact factor: 6.570

Review 3.  Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.

Authors:  Michael Hecker; Jan Bühring; Brit Fitzner; Paulus Stefan Rommer; Uwe Klaus Zettl
Journal:  Biomolecules       Date:  2021-10-13

4.  Circulating endothelial progenitor cells during pregnancy in multiple sclerosis.

Authors:  Giulia Mallucci; Fausta Beneventi; Roberto Bergamaschi; Cristina Bizzotto; Chiara Cavagnoli; Irene De Maggio; Camilla Bellingeri; Cristina Monti; Gianluca Viarengo; Arsenio Spinillo
Journal:  Neurol Sci       Date:  2020-08-17       Impact factor: 3.307

Review 5.  Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy's Impact on Disease Activity.

Authors:  Guoda Varytė; Jolita Zakarevičienė; Diana Ramašauskaitė; Dalia Laužikienė; Audronė Arlauskienė
Journal:  Medicina (Kaunas)       Date:  2020-01-21       Impact factor: 2.430

6.  Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience.

Authors:  Aurora Zanghì; Emanuele D'Amico; Graziella Callari; Clara Grazia Chisari; Giovanna Borriello; Luigi Maria Edoardo Grimaldi; Francesco Patti
Journal:  Front Neurol       Date:  2020-02-25       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.